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Purpose. Type 2 diabetes consists of progressive hyperglycemia and insulin resistance, which could result from glucose toxicity,
inflammatory cytokines, and oxidative stress. In the present study we investigated the effect of Gelam honey and quercetin on the
oxidative stress-induced inflammatory pathways and the proinflammatory cytokines. Methods. HIT-T15 cells were cultured and
preincubated with the extract of Gelam honey (20, 40, 60, and 80𝜇g/mL), as well as quercetin (20, 40, 60, and 80 𝜇M), prior to
stimulation by 20 and 50 mM glucose. Results.HIT-T15 cells cultured under hyperglycemic condition showed a significant increase
in the inflammatory pathways by phosphorylating JNK, IKK-𝛽, and IRS-1 at Ser307 (𝑝 < 0.05). There was a significant decrease
in the phosphorylation of Akt at Ser473 (𝑝 < 0.05). Pretreatment with Gelam honey and quercetin reduced the expression of
phosphorylated JNK, IKK-𝛽, and IRS-1, thereby significantly reducing the expression of proinflammatory cytokines like TNF-𝛼,
IL-6, and IL-1𝛽 (𝑝 < 0.05). At the same time there was a significant increase in the phosphorylated Akt showing the protective
effects against inflammation and insulin resistance (𝑝 < 0.05). In conclusion, our data suggest the potential use of the extract from
Gelam honey and quercetin in modulating the inflammation induced insulin signaling pathways.
1. Research Background
Diabetes is one of the most common noncommunicable
diseases affecting millions of people globally [1, 2]. It is one
of the most challenging health problems in many developing
and industrialized countries and the exact cause is unknown.
One of the foremost challenges we now face is to account
mechanistically not only for the definition of hyperglycemia,
but also for other physiological and biochemical abnormali-
ties, which are the characteristics of the disease [3, 4].
Type 2 diabetes consists of progressive hyperglycemia,
insulin resistance, and pancreatic 𝛽 cell failure. The patho-
genesis of type 2 diabetes is complex and in most instances
clearly requires defects in both 𝛽 cell function and insulin
sensitivity, and together both of these abnormalities bring
about hyperglycemia. Type 2 diabetes has a metabolic milieu,
which is characterized by insulin resistance and chronic acute
inflammation. In the last decade, a great deal of attention
has been focused on the understanding of insulin resistance
which is an important contributor to the development and
maintenance of hyperglycemia in type 2 diabetes [5, 6].
Β cell dysfunction can result from glucose toxicity,
inflammatory cytokines, oxidative stress, or lipotoxicity in
the presence of excess glucose. Oxidative stress through
the production of reactive oxygen species (ROS) has been
proposed as the root cause underlying the development
of insulin resistance, 𝛽 cell dysfunction, impaired glucose
tolerance, and type 2 diabetes mellitus [3].
Oxidative stress is induced by reactive oxygen and
nitrogen species produced by several biochemical pathways
associatedwith hyperglycemia (glucose autooxidation, polyol
pathway, prostanoid synthesis, and protein glycation) and
is critically involved in the impairment of 𝛽 cell function
during the development of type 2 diabetes [7, 8]. Reactive
oxygen species can function as signalingmolecules to activate
a number of stress sensitive pathways and inflammatory
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pathways leading to the production of inflammatory markers
such as IL-6 and TNF-𝛼 that impair insulin signaling through
serine phosphorylation of IRS-1 [9].
Insulin is a pleiotropic hormone which has many func-
tions that are exerted across a variety of insulin target tissues,
through several intracellular signaling cascades. Insulin sub-
strate (IRS-1) mediated insulin signaling regulates peripheral
insulin action as well as pancreatic 𝛽 cell function by regulat-
ing proliferation, survival, and insulin secretion. The defects
in insulin signaling pathwaymainly involve IRS-1. Activation
of the insulin receptor leads to tyrosine phosphorylation of
IRS-1, thereby initiating signal transduction. Insulin receptor
tyrosine kinases can signal through the phosphatidylinositol
3-kinase (PI3K) pathway, which is mainly responsible for the
metabolic actions of insulin. The major target of PI3K is the
serine threonine kinase Akt. It has been shown that the Akt
dependent mechanism in the distal events of exocytosis is
responsible for the defect in insulin secretion [7, 10].
This transient exposure of 𝛽 cells to oxidative stress
interrupts the normal coupling of glucose metabolism to
insulin secretion by activating stress signaling pathways and
the inflammatory pathways [11]. Despite the multiplicity of
inflammatory pathways, the development of insulin resis-
tance is often due to the activation of jun-N-terminal kinase
(JNK) and the IkappaB kinase (IKK-𝛽). The JNK and IKK-
𝛽 pathways are activated by ROS and various other factors
including the inflammatory cytokines such as TNF-𝛼, IL-6,
and IL-1betawhich are involved in the development of insulin
resistance found in type 2 diabetes [12].
Reactive oxygen species and mitochondrial stress-
induced [13] activation of JNK and IKK-𝛽 promotes the
phosphorylation of IRS-1 at serine sites that negatively
regulate normal signaling through the insulin receptor/IRS-1
axis, as seen in the phosphorylation of IRS-1 at serine 307
(Ser307). It has been reported that serine phosphorylation
of insulin receptor-1 (IRS-1) inhibits insulin stimulated
tyrosine phosphorylation of IRS-1 leading to an increase in
insulin resistance [10]. Therefore, one of the causes leading
to a defect in insulin signaling can be attributed to serine
phosphorylation of IRS-1 at serine 307 residues which
activate the jun-N-terminal kinase (JNK) and IKK-𝛽, thus
providing a plausiblemechanistic link between inflammation
and insulin resistance [14].
Recently, protein kinase B (PKB andAkt) has been shown
to function in the insulin signaling cascade by phospho-
rylating transcription factors which are responsible for the
transcription and expression of genes, related to insulin
synthesis and secretion. Previous studies have shown that
inactivation of Akt can lead to insulin resistance, decreased
𝛽 cell mass, and impaired insulin secretion [15].
Numerous studies have shown that honey has antioxidant
and scavenging properties, which prevents the oxidative
damage caused by free radicals. The antioxidant property
is due to the phenolic compounds which are present in
the honey and it has been demonstrated that the biolog-
ical activities correlate with the phenolic content of the
honey [16]. The phenolic content of the Malaysian Gelam
honey has been shown to have both anti-inflammatory
and antioxidant properties [17]. Quercetin is one of the
important components of Gelam honey that may be further
elaborated in terms of its function and use as antidiabetic
agent.
Therefore, the aim of our present study is to determine
the effect of Gelam honey extract and quercetin on the
JNK and IKK-𝛽 inflammatory pathways and IRS-1 serine
phosphorylation which causes insulin resistance and the Akt
activated insulin signaling pathway, which improves insulin
resistance.
2. Research Design and Methods
2.1. Extraction of Phenolic Compounds from Honey by Solid
Phase Extraction (SPE). Gelam honey samples (Department
of Agriculture, Parit Botak, Johor, Malaysia) were sub-
jected to base hydrolysis and extracted with ethyl acetate
as described by Wahdan [18] and Seo and Morr [19]. The
recovered fractions were combined and dried under nitrogen
gas.
2.2. Determination of the Phenolic Content. Phenolic com-
pounds from the extract were assayed using Folin-Ciocalteu
assay [20]. Briefly the extract (1mL) was added to 10% Folin-
Ciocalteu reagent (Sigma F9252) and 0.5% sodium carbonate.
The contents were thoroughly mixed and allowed to stand
for 2 hours. The absorbance of the blue color that developed
after 2 hours was read at 765 nm. Results were expressed in
micrograms of Gallic acid per gram of the extract, using a
standard curve generated with Gallic acid (Sigma G7384).
2.3. Determination of the Flavonoid Content. The total
flavonoid (TF) content was determined spectrophotometri-
cally. Briefly 1mL of honey extract or a standard solution
of quercetin (Sigma Q4951) (10, 50, 100, 150, 200, and
250 𝜇g/mL) in distilled water was added to a 10mL volumet-
ric flask containing 4mL of double distilled water, 300𝜇L
of NaNO
2
(5%, v/v), and 300 𝜇L of 10% AlCl
3
. The solution
was allowed to stand at room temperature in the dark for
30 minutes and the absorbance was read at 430 nm. The TF
contentwas determinedusing the standard curve of quercetin
(𝜇g/mL) and was expressed as 𝜇g of quercetin equivalents in
1 g of extract.
2.4. Cell Culture. HIT-T15 cells were cultured according to
the instructions provided by ATCC (CRL-1777). On arrival
the cells were cultured immediately in T-25 cm flask in the
F12K medium (ATCC 30-2004) supplemented with 10% FBS
and 1% penicillin and streptomycin at 37∘C (5% CO
2
in
air). Cells (3rd passage) were trypsinized and subcultured,
following which they were incubated for 5 days until they
reached 80% confluency.
2.5. Treatment of HIT-T15 Cells with Quercetin and Gelam
Honey Extract. HIT-T15 cells (5 × 105) were pretreated
with Gelam honey extract (20, 40, 60, and 80 𝜇g/mL) and
quercetin (20, 40, 60, and 80 𝜇M) for 24 hours, after which
the medium was replaced with fresh medium. Following this
glucose (SigmaG8769) (20 or 50mM)was added and the cells
were incubated for another 24 hours.
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2.6. Cell Lysate Preparation. After treatment the cells were
washed twice in PBS and lysed in mammalian cell lysis buffer
(Sigma MCL-1 which was supplemented with protease and
phosphatase inhibitors. Insoluble materials were eliminated
by centrifugation (12,000×g, 10min, 4∘C), and the protein
concentration in the supernatant was determined by Brad-
ford assay (Bio-Rad Laboratories).
2.7. Western Blot Analysis. Thirty micrograms of protein
extracts was loaded on 10% SDS-polyacrylamide gel and
transferred to activated nitrocellulose membrane. The mem-
branes were blocked with tris-buffered saline (TBS) contain-
ing 5% nonfat milk and incubated with pAkt (Ser473), pIRS-
1 (Ser307), p-JNK, p-IKK-𝛼/𝛽, IL-6, IL-1𝛽, and TNF alpha
primary antibodies (obtained from Santa Cruz Laboratories)
overnight at 4∘C with a concentration of 1 : 1000. 𝛽-actin was
used as a loading control. After 3 times extensive washes
in TBS (for 20–30m each), membranes were incubated for
1 h at room temperature with the appropriate horseradish
peroxidase-conjugated secondary antibodies. We use the
concentration of 1 : 5000 for secondary antibodies. Then
we visualized the film using chemiluminescence substrate
according to the manufacturer’s instructions (Amersham
Life Sciences, Little Chalfont, UK). Quantitative analysis of
the protein content was performed by Gel Documentation
System (Biospectrum 410, UVP).
2.8. Statistical Analyses. Data were analyzed with one-way
ANOVA using SPSS version 16.0 software. The results were
expressed as the mean ± standard deviation value. ∗𝑝 < 0.05
was considered to be statistically significant.
3. Results
3.1. Total Phenolic and Flavonoid Content. 10 g of liquefied
fresh Malaysian Gelam honey (Apis mellifera) was extracted
using ethyl acetate and the extract was found to contain 52 𝜇g
of Gallic acid per gram of extract of total phenolic content
and 6.92 𝜇g of quercetin per gram of extract of total flavonoid
content.
In our previous paper [21] we demonstrated the presence
of ROS by using 2󸀠7󸀠-dichlorodihydrofluorescein diacetate
(DCFH-DA) reagent under hyperglycemic conditions and
by the measurement of intracellular ROS in individual
cells by image analysis. Our data showed the antioxidant
effect of Gelam honey extract and the flavonoid compounds
quercetin, luteolin, and chrysin in the cultured cells by
significantly inhibiting the production of ROS in a dose
dependent manner. Again our data showed the reduction of
ROS in the single cells in a dose dependent manner after
pretreatment with the honey extract and the flavonoids.
3.2. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on Phospho-JNKExpression under Normal andHyper-
glycemic Conditions. HIT-T15 cells were pretreated with the
quercetin at concentrations of 20, 40, 60, and 80𝜇M and
Gelam honey extract at concentrations of 20, 40, 60, and
80 𝜇g/mL for 24 hours, following which they were cul-
tured with 20mM (Figures 1(a), 1(c), and 1(e)) or 50mM
(Figures 1(b), 1(d), and 1(f)) glucose to determine the phos-
phorylation of JNK. The data revealed that exposure of HIT-
T15 cells to 20 and 50mM glucose significantly increased
the level of phospho-JNK expression compared to control.
Pretreatment with quercetin and Gelam honey extract signif-
icantly (𝑝 < 0.05) reduced the ROS induced expression of
phospho-JNK under 20mM glucose (Figures 1(a), 1(c), and
1(e)) by 60% and 42% in a dose dependent manner. Pre-
treatment with quercetin and Gelam honey extract reduced
the expression of phospho-JNK significantly (𝑝 < 0.05) by
64% and 50%, respectively, compared to the cells that were
cultured with 50mM glucose (Figures 1(b), 1(d), and 1(f))
alone. The phospho-JNK protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated group)
(Figure 1).
3.3. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on Phospho-IKK-𝛽 Expression under Normal and
Hyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, and
80 𝜇M and Gelam honey extract at concentrations of 20,
40, 60, and 80 𝜇g/mL for 24 hours, following which they
were cultured with 20mM (Figures 2(a), 2(c), and 2(e)) or
50mM (Figures 2(b), 2(d), and 2(f)) glucose to determine
the phosphorylation of IKK-𝛽. The phosphorylation of IKK-
𝛽 was increased in HIT-T15 cells treated with 20mM and
50mM glucose alone as compared with control. Pretreat-
ment with the quercetin and Gelam honey extract showed
55% and 44% decrease (𝑝 < 0.05) in the expression of
phosphorylated IKK-𝛽 in a dose dependent manner in the
cells that were cultured in 20mM (Figures 2(a), 2(c), and
2(e)) glucose. Pretreatment with quercetin and Gelam honey
extract significantly (𝑝 < 0.05) decreased the expression of
phosphorylated IKK-𝛽 under 50mM glucose (Figures 2(b),
2(d), and 2(f)) by 60% and 47% in a dose dependent manner.
The phosphorylated IKK-𝛽 protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated group)
(Figure 2).
3.4. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on IL-6 Expression under Normal and Hyperglycemic
Conditions. HIT-T15 cells were pretreated with the quercetin
at concentrations of 20, 40, 60, and 80 𝜇M and Gelam honey
extract at concentrations of 20, 40, 60, and 80𝜇g/mL for 24
hours, following which they were cultured in 20mM (Figures
3(a), 3(c), and 3(e)) or 50mM (Figures 3(b), 3(d), and 3(f))
glucose to determine the expression of IL-6. The expression
was increased in HIT-T15 cells treated with 20mM and
50mMglucose alone as comparedwith control. Pretreatment
with the quercetin and Gelam honey extract showed 52%
and 40% decrease (𝑝 < 0.05) in the expression of IL-6 in
a dose dependent manner in the cells that were cultured in
20mM glucose (Figures 3(a), 3(c), and 3(e)). Pretreatment
with quercetin and Gelam honey extract significantly (𝑝 <
0.05) decreased the expression of IL-6 under 50mM glucose
(Figures 3(b), 3(d), and 3(f)) by 60% and 47% in a dose
dependent manner.The IL-6 protein levels from each sample
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Figure 1: Effect of quercetin and Gelam honey extract on phospho-JNK expression. Quantitative analysis and representative western blot
analysis of phospho-JNK in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and
50mM ((b), (d), and (f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS
version 16.0 software and are presented as themean ± standard deviation and represent themean of three different experiments. (e) ∗𝑝 < 0.05
and #𝑝 < 0.005, quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and
honey extract treated compared to the 50mM glucose alone.
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated
group).
3.5. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on IL-1𝛽 Expression under Normal and Hyperglycemic
Conditions. HIT-T15 cells were pretreated with the quercetin
at concentrations of 20, 40, 60, and 80 𝜇M and Gelam
honey extract at concentrations of 20, 40, 60, and 80 𝜇g/mL
for 24 hours, following which they were then cultured
with 20 or 50mM glucose to determine the expression
of IL-1𝛽. IL-1𝛽 in HIT-T15 cells was markedly increased
following 20mM (Figures 4(a), 4(c), and 4(e)) and 50mM
(Figures 4(b), 4(d), and 4(f)) glucose treatment, but the
trend was reversed after pretreatment with quercetin and
Gelam honey extract. Pretreatment of the cells with different
concentration of quercetin and honey extract for 24 hours
significantly reduced the expression of IL-1𝛽 up to 55% and
42%, respectively, compared to the cells that were cultured
alone with 20mM glucose (Figures 4(a), 4(c), and 4(e)).
On the other hand, pretreatment with quercetin and honey
extract reduced the expression of IL-1𝛽 significantly (𝑝 <
0.05) up to 63% and 54%, respectively, compared to the cells
that were cultured alone with 50mM glucose (Figures 4(b),
4(d), and 4(f)). The IL-1𝛽 protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated group),
Figure 3.
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Figure 2: Effect of quercetin and Gelam honey extract on phospho-IKK-𝛽 expression. Quantitative analysis and representative western blot
analysis of phospho-IKK-𝛽 in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and
50mM ((b), (d), and (f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS
version 16.0 software and are presented as themean ± standard deviation and represent themean of three different experiments. (e) ∗𝑝 < 0.05
and #𝑝 < 0.005, quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and
honey extract treated compared to the 50mM glucose alone.
3.6. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on TNF Alpha Expression under Normal and Hyper-
glycemic Conditions. HIT-T15 cells were pretreated with the
quercetin at concentrations of 20, 40, 60, and 80𝜇M and
Gelam honey extract at concentrations of 20, 40, 60, and
80 𝜇g/mL for 24 hours, following which they were then
cultured with 20mM (Figures 5(a), 5(c), and 5(e)) or 50mM
(Figures 5(b), 5(d), and 5(f)) glucose to determine the TNF
alpha. The TNF alpha was increased in HIT-T15 cells treated
with 20mM and 50mM glucose alone as compared with
control. Pretreatment with the quercetin and Gelam honey
extract showed 43% and 55% decrease (𝑝 < 0.05) in the
expression of TNF alpha in a dose dependent manner in
the cells that were cultured in 20mM glucose (Figures 5(a),
5(c), and 5(e)). Pretreatmentwith quercetin andGelamhoney
extract significantly (𝑝 < 0.05) decreased the expression of
TNF alpha in a dose dependent manner, in the cells cultured
with 50mM glucose (Figures 5(b), 5(d), and 5(f)) by 52%
and 66%. The TNF alpha protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated group)
(Figure 5).
3.7. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on pIRS-1 (Ser307) Expression under Normal and
Hyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, and
80 𝜇M and Gelam honey extract at concentrations of 20, 40,
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Figure 3: Effect of quercetin and Gelam honey extract on IL-6 expression. Quantitative analysis and representative western blot analysis of
IL-6 in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and 50mM ((b), (d), and
(f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS version 16.0 software
and are presented as the mean ± standard deviation and represent the mean of three different experiments. (e) ∗𝑝 < 0.05 and #𝑝 < 0.005,
quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and honey extract treated
compared to the 50mM glucose alone.
60, and 80 𝜇g/mL for 24 hours, following which they were
then cultured with 20mM (Figures 6(a), 6(c), and 6(e)) or
50mM (Figures 6(b), 6(d), and 6(f)) glucose to determine
the phosphorylation of IRS-1 (Ser307). The phosphorylation
of IRS-1 (Ser307) was increased in HIT-T15 cells treated with
20mM and 50mM glucose alone as compared with control.
Pretreatment with the quercetin and Gelam honey extract
showed 49% and 55% decrease (𝑝 < 0.05) in the expression
of pIRS-1 (Ser307) in a dose dependent manner in the cells
that were cultured in 20mM glucose (Figures 6(a), 6(c),
and 6(e)). Pretreatment with quercetin and Gelam honey
extract significantly (𝑝 < 0.05) decreased the expression
of pIRS-1 (Ser307) in cells that were cultured in 50mM
glucose (Figures 6(b), 6(d), and 6(f)) by 43% and 60% in a
dose dependent manner. The pIRS-1 protein levels from each
sample were normalized to their respective 𝛽-actin protein
amounts (∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated
group) (Figure 6).
3.8. Effect of Pretreatment with Quercetin and Gelam Honey
Extract on pAkt (Ser473) Expression under Normal and
Hyperglycemic Conditions. HIT-T15 cells were pretreated
with the quercetin at concentrations of 20, 40, 60, and
80 𝜇M and Gelam honey extract at concentrations of 20, 40,
60, and 80 𝜇g/mL for 24 hours, following which they were
then cultured with 20 or 50mM glucose to determine the
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Figure 4: Effect of quercetin and Gelam honey extract on IL-1𝛽 expression. Quantitative analysis and representative western blot analysis
of IL-1𝛽 in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and 50mM ((b), (d), and
(f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS version 16.0 software
and are presented as the mean ± standard deviation and represent the mean of three different experiments. (e) ∗𝑝 < 0.05 and #𝑝 < 0.005,
quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005 quercetin and honey extract treated
compared to the 50mM glucose alone.
phosphorylation of Akt (Ser473). There was no change in the
Akt (Ser473) phosphorylation in HIT-T15 cells when treated
with 20 mM glucose (Figures 7(a), 7(c), and 7(e)) but it was
markedly reduced when the cells were treated with 50mM
(Figures 7(b), 7(d), and 7(f)) glucose. Pretreatment of the
cells with different concentration of quercetin and honey
extract for 24 hours significantly increased the expression of
pAkt (Ser473) up to 38% and 70%, respectively, compared
to the cells that were cultured alone with 20mM glucose
(Figures 7(a), 7(c), and 7(e)).On the other hand, pretreatment
with quercetin and honey extract increased the expression
of pAkt (Ser473) significantly (𝑝 < 0.05) up to 30% and
54%, respectively, compared to the cells that were cultured
alone with 50mM glucose (Figures 7(b), 7(d), and 7(f)). The
cells that were exposed to Akt inhibitor VIII prevented the
quercetin and honey extract induced Akt Ser473 phosphory-
lation (Figure 7). The pAkt protein levels from each sample
were normalized to their respective 𝛽-actin protein amounts
(∗𝑝 < 0.05 and #𝑝 < 0.005 versus glucose treated group)
(Figure 7).
4. Discussion
In our previous study we investigated the antioxidant effect
of the Malaysian Gelam honey and some of its flavonoid
components (chrysin, luteolin, and quercetin) individu-
ally, on pancreatic hamster cells (HIT-T15) cultured under
hyperglycemic conditions. Our data demonstrated that the
cultured cells, pretreated with the extract of the Gelam
honey and the different flavonoid components (quercetin,
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Figure 5: Effect of quercetin andGelamhoney extract onTNF alpha expression.Quantitative analysis and representativewestern blot analysis
of TNF alpha in HIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and 50mM ((b), (d),
and (f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS version 16.0
software and are presented as the mean ± standard deviation and represent the mean of three different experiments. (e) ∗𝑝 < 0.05 and
#𝑝 < 0.005, quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and honey
extract treated compared to the 50mM glucose alone.
luteolin, and chrysin) at varying concentrations for 24 hours,
protected the 𝛽 cell from oxidative damage caused by ROS
induced by hyperglycemia [21]. Furthermore, we investigated
the effect of Gelam honey extract and quercetin on the stress
activated NF-𝜅B andMAPK pathways and IRS-1 serine phos-
phorylation causing insulin resistance and the Akt activated
insulin signaling pathway, causing increase in insulin content.
Our data demonstrated that the Gelam honey extract and
quercetin had the best protective effect against hyperglycemia
induced oxidative stress by improving the insulin content and
insulin resistance [22].
The floral source of Gelam honey is Melaleuca cajuputi.
This was the only source of Gelam honey that was used in
Kamaruddin et al. laboratory and different students worked
on the different aspects of this honey. They were the first to
establish the detection of the phenolic compounds in Gelam
honey found in Malaysia using HPLC [23]. Chromatogram
of phenolic acid and flavonoids detected in Malaysian Gelam
honey, using HPLC-UV absorption (1) 290 nm and (2)
340 nm, is shown in the paper of the same group [24]. In our
previous study we used three different flavonoids: chrysin,
luteolin, and quercetin [21, 22]. This shows that the quercetin
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Figure 6: Effect of quercetin on pIRS-1 (Ser307) expression. Quantitative analysis and representative western blot analysis of pIRS-1 (Ser307)
in HIT-T15 cells pretreated with quercetin and Gelam honey extract in cells cultured in 20mM ((a), (c), and (e)) and 50mM ((b), (d), and
(f)) glucose. The results were normalized with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS version 16.0 software
and are presented as the mean ± standard deviation and represent the mean of three different experiments. (e) ∗𝑝 < 0.05 and #𝑝 < 0.005,
quercetin and honey extract treated compared to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005 quercetin and honey extract treated
compared to the 50mM glucose alone.
was themost effective amongst the three flavonoids.Thework
on caffeic acid on the same Gelam honey has already been
published by the above-mentioned group [25, 26].
Therefore, in our present study, we determined the effect
of Gelam honey extract and quercetin on the oxidative stress
activated JNK and IKK-𝛽 inflammatory pathways and IRS-
1 serine phosphorylation causing insulin resistance and the
Akt activated insulin signaling pathway, which attenuates the
inflammation, thereby increasing insulin sensitivity.
Several studies have demonstrated that flavonoids may
reduce hyperglycemia and exert protective effects against
nonenzymatic glycation of proteins in animals [27, 28].
The flavonoid quercetin in particular has been reported to
have anti-inflammatory properties in diabetic animalmodels,
by protecting the retinal cell apoptosis in diabetes [29].
Under diabetic conditions, hyperglycemia induced ROS and
inflammatory cytokines presumably lead to the activation of
the JNK and IKK-𝛽 pathways. It has been shown that IKK and
JNK control the major inflammatory response pathways in
hyperglycemia and that they are activated by oxidative stress
[30, 31].
Yuan et al. [32] demonstrated that reduced signaling
through the IKK-𝛽 pathway inhibition by sodium salicy-
late in obese mice is accompanied by improved insulin
sensitivity. Again the study showed that phosphorylation
of IKK-𝛽 was increased in diabetes, but the blockade
of NF-𝜅B, oxidative stress, and the genetic deletion of
TNF-𝛼 attenuated phosphorylation of IKK-𝛽, suggesting
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Figure 7: Effect of quercetin and Gelam honey extract on pAkt (Ser473) expression. Quantitative analysis and representative western blot
analysis of pAkt (Ser473) inHIT-T15 cells pretreated with quercetin and honey extract in cells cultured in 20mM ((a), (c), and (e)) and 50mM
((b), (d), and (f)) glucose. An increase in the level of pAkt (Ser473) was observed after pretreatment with quercetin and honey extract. Akt
inhibitor VIII prevented the expression of Akt Ser473 phosphorylation induced by quercetin and honey extract. The results were normalized
with 𝛽-actin antibody. Data were analyzed with one-way ANOVA using SPSS version 16.0 software and are presented as the mean ± standard
deviation and represent the mean of three different experiments. (e) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and honey extract treated compared
to the 20mM glucose alone. (f) ∗𝑝 < 0.05 and #𝑝 < 0.005, quercetin and honey extract treated compared to the 50mM glucose alone.
that the phosphorylation of IKK-𝛽 is increased in dia-
betic mice by the activation of oxidative stress and TNF-𝛼
[33].
The increase in free fatty acids, inflammatory cytokines,
and oxidative stress under diabetic conditions activates the
JNK pathway which causes insulin resistance and pancreatic
𝛽 cell dysfunction [34]. It has been reported that the JNK
pathway was abnormally activated in the liver, muscle, and
adipose tissue in obese type 2 diabetic mice and that the
insulin resistance was substantially reduced when the mice
were homozygous for a targeted mutation in the JNK1 gene.
Our data showed that exposure of HIT-T15 cells to 20
and 50mM glucose caused a significant increase in the level
of phosphorylated JNK (Figure 1) and phosphorylated IKK-𝛽
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(Figure 2) expressions compared to the control. Pretreatment
with quercetin and Gelam honey extract significantly (𝑝 <
0.05) reduced the ROS induced inflammatory pathway of
phosphorylated JNK (Figure 1) and phosphorylated IKK-𝛽
(Figure 2) when treated with 20 and 50mM glucose. This
gives further support to the fact that oxidative stress induced
by high glucose activates the major inflammatory pathways.
It has been shown that hyperglycemia is proinflammatory
and is normally restrained by the anti-inflammatory effect
of insulin secreted in response to that stimulus [35]. Hyper-
glycemia induced by glucose clamping in normal subjects
showed a significant increase in the circulating levels of
interleukin- (IL-) 6, IL-18, Il-1𝛽, and tumor necrosis factor-
𝛼 (TNF-𝛼). These effects were more sustained in patients
with impaired glucose tolerance as well as in those after con-
secutive pulses of intravenous glucose, which were annulled
by glutathione, implicating an oxidative mechanism [31].
Interestingly enough, these cytokines have been implicated
in insulin resistance (TNF-𝛼, IL-6, and IL-1𝛽), atheroscle-
rotic plaque destabilization (IL-18), and future cardiovascular
events (IL-6, IL-18, IL-1𝛽, and TNF-𝛼). So, an increased
oxidative stress may be a likely mechanism linking stress
hyperglycemia to increased inflammatory cytokine produc-
tion [31, 34]. Several cross-sectional studies showed that
insulin resistance and type 2 diabetes are associated with
higher levels of C-reactive protein (CRP), interleukin-6 (IL-
6), interleukin-1𝛽, and tumor necrosis factor-𝛼 (TNF-𝛼),
which are markers of subclinical systemic inflammation [35].
Furthermore, various longitudinal studies have shown that
elevated levels of CRP, IL-1𝛽, IL-6, and TNF-𝛼 predict the
development of type 2 diabetes [35].
Our data supported the above statement by showing that
TNF-𝛼, IL-6, and IL-1𝛽 expressions (Figures 3, 4, and 5)
in HIT-T15 cells were markedly increased following 20 and
50mM glucose treatment but were reversed after pretreat-
ment with quercetin and Gelam honey extract. In addition,
our data showed that the expression of TNF-𝛼, IL-6, and IL-
1𝛽 (Figures 3, 4, and 5) was decreased.
Our previous data demonstrated that Akt (Ser473) phos-
phorylation was increased after pretreatment with quercetin
and honey extract (REF). Effect of Gelam honey on the
oxidative stress induced signaling pathways in pancreatic
hamster cells [22].
In the year 2001 it was reported thatmice lacking the pAkt
(Ser473) protein were insulin resistant, with impaired insulin
secretion [36]. It was shown that Akt (Ser473) is necessary
for normal pancreatic 𝛽 cell function including a novel
regulatory role for Akt signaling in insulin secretion [37].
Several studies reported that a decrease in insulin secretion
and insulin resistance induced by hyperglycemia has been
associated with decreased Akt activity [38–41].
In our previous papers [21, 22] we showed that the cells
cultured under 20mM glucose did not show any changes at
the level of the Akt phosphorylation while under 50mM the
Akt (serine 473) phosphorylation was reduced significantly.
The phosphorylation was increased significantly after pre-
treatment with quercetin and honey extract. Akt inhibitor
VIII prevented the expression of Akt Ser473 phosphorylation
induced by quercetin and honey extract. When we studied
the insulin content our data demonstrated that there was
a significant increase in the insulin content (𝑝 < 0.05)
when the cells cultured under 20mMglucose were pretreated
with quercetin and honey extract, but there was a significant
decrease in the insulin content (𝑝 < 0.05) when the cells
were treated with Akt inhibitor VIII, before pretreating with
quercetin and Gelam honey extract when the cells were
cultured in 50mM glucose, and there was a significant
increase in the insulin content (𝑝 < 0.05 and 𝑝 < 0.005)
when the cells were pretreated with quercetin and Gelam
honey extract. A significant decrease was seen (𝑝 < 0.05 and
𝑝 < 0.005) when the cells were treatedwithAkt inhibitor VIII
before pretreating with quercetin and Gelam honey extract.
Thus, our data demonstrated the protective effects of Akt
against 𝛽 cell dysfunction and insulin resistance, which was
further supported by the fact that Akt inhibitor increased
the insulin resistance by decreasing the quantity of insulin
secreted.
It has been shown that activation of the IKK-𝛽 and JNK
pathways increases IRS-1 serine phosphorylation which leads
to suppression of insulin signaling and that suppression of
the IKK pathway decreases insulin resistance and ameliorates
glucose intolerance in diabetic mice [29]. Our data which
supports the above statement showed that phosphorylation
of IRS-1 (Ser307) was increased in HIT-T15 cells treated
with 20 and 50mM glucose alone as compared with control.
Pretreatment with the quercetin and Gelam honey extract
significantly decreased (𝑝 < 0.05) the expression of pIRS-1
(Ser307) (Figure 6) in a dose dependent manner in the cells
that were cultured in 20 and 50mM glucose (Figure 6). Our
data suggest that there is decrease in phosphorylation of IRS-
1(Ser307) (Figure 6).
5. Conclusion
In conclusion our data suggest the potential use of the extract
from Gelam honey in treating diabetes, by modulating the
inflammatory pathways. The data provide further support
to the role of inflammation in 𝛽 cell dysfunction and
insulin resistance. In addition, since stress-induced JNK and
IKK pathways are involved in the development of insulin
resistance, inflammation, and 𝛽 cell dysfunction, it is possible
that such pathways could be a therapeutic target for type 2
diabetes.
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